Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

383
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
383
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

63
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
63
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

459
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
459
Classification of Illness01:17

Classification of Illness

8.1K
The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.1K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

3.3K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.3K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

101
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
101

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).

Reviews in endocrine & metabolic disorders·2026
Same author

A systematic review of obesity burden in Saudi Arabia: Prevalence and associated co-morbidities.

Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society·2026
Same author

Acute Cerebellitis With a Cross-Reactivity of COVID-19 and Influenza A.

Cureus·2026
Same author

Postangiography Prediction of Renal Replacement Therapy in Acute Myocardial Infarction-Related Cardiogenic Shock: Least Absolute Shrinkage and Selection Operator Nomogram Development and Validation.

JMIR cardio·2026
Same author

Phakomatosis Pigmentovascularis (Type IIb) With Bilateral Glaucoma and Urrets-Zavalia Syndrome Following MicroPulse TSCPC: A Case Report.

Case reports in ophthalmological medicine·2026
Same author

Overcoming the barriers in the screening, diagnosis, and follow-up of patients with metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH).

Reviews in endocrine & metabolic disorders·2026
Same journal

RETRACTED: Zhang et al. A Novel Framework for Reconstruction and Imaging of Target Scattering Centers via Wide-Angle Incidence in Radar Networks. <i>Sensors</i> 2025, <i>25</i>, 6802.

Sensors (Basel, Switzerland)·2026
Same journal

Enhancing Unsupervised Multi-Source Domain Adaptation for Person Re-Identification via Mixture of Experts and Graph-Based Relation.

Sensors (Basel, Switzerland)·2026
Same journal

Development of an Instrumented Glove for Palmar Pressure Assessment in Kayakers.

Sensors (Basel, Switzerland)·2026
Same journal

Development and Experimental Validation of an Autonomous IoT-Based Monitoring System for Real-Time Water Quality Assessment in the Amazon River.

Sensors (Basel, Switzerland)·2026
Same journal

Semi-Supervised Adversarial Learning Framework for Controller Area Network Bus Intrusion Detection.

Sensors (Basel, Switzerland)·2026
Same journal

Smart Optimization Method for Safety Signs in Innovative Manufacturing Environments Integrating Industrial Field IoT Sensors and Knowledge Graphs.

Sensors (Basel, Switzerland)·2026
See all related articles

Related Experiment Video

Updated: Oct 3, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.4K

Multi-Label Active Learning-Based Machine Learning Model for Heart Disease Prediction.

Ibrahim M El-Hasnony1, Omar M Elzeki1,2, Ali Alshehri3

  • 1Faculty of Computers and Information Sciences, Mansoura University, Mansoura 35516, Egypt.

Sensors (Basel, Switzerland)
|February 15, 2022
PubMed
Summary
This summary is machine-generated.

This study optimized machine learning models for heart disease prediction using active learning (AL) strategies. Optimized models improved accuracy and F-score, aiding early detection and preventive care for cardiovascular diseases.

Keywords:
active learningchronic diseasesdata miningheart diseasemachine learningmulti-label classification

More Related Videos

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.0K

Related Experiment Videos

Last Updated: Oct 3, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.4K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.0K

Area of Science:

  • Medical Informatics
  • Machine Learning
  • Cardiovascular Health

Background:

  • Modern healthcare systems leverage data for trend identification and preventive care.
  • Heart disease is a leading cause of mortality, with complications like dementia potentially preventable through early detection.
  • Machine learning (ML) offers potential for predicting and diagnosing heart disease using extensive healthcare data.

Purpose of the Study:

  • To evaluate multi-label active learning (AL) selection strategies for reducing labeling costs in heart disease prediction.
  • To optimize machine learning models for heart disease diagnosis using hyperparameter tuning.
  • To compare the performance of different AL strategies in conjunction with a label ranking classifier.

Main Methods:

  • Applied five multi-label active learning selection strategies (MMC, Random, Adaptive, QUIRE, AUDI) to a heart disease dataset.
  • Utilized a label ranking classifier with hyperparameters optimized via grid search for predictive modeling.
  • Evaluated model performance using accuracy and F-score metrics, with and without hyperparameter optimization.

Main Results:

  • The optimized label ranking model demonstrated superior generalization capabilities, particularly in terms of accuracy, compared to other selection methods.
  • Specific selection methods showed enhanced performance regarding F-score when utilizing optimized settings.
  • Hyperparameter optimization significantly impacted the predictive performance of the ML models.

Conclusions:

  • Optimized machine learning models, particularly with advanced active learning strategies, can effectively improve the prediction and diagnosis of heart disease.
  • The choice of active learning selection strategy and hyperparameter optimization are crucial for maximizing model performance (accuracy and F-score).
  • This research contributes to developing more efficient and accurate ML-based systems for early detection and prevention of cardiovascular diseases.